Cameco Corporation (NYSE:CCJ) Shares Acquired by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. boosted its position in shares of Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 66.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 447,581 shares of the basic materials company's stock after buying an additional 179,387 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.10% of Cameco worth $18,422,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CCJ. Hurley Capital LLC acquired a new stake in Cameco during the fourth quarter valued at $27,000. Copia Wealth Management acquired a new stake in Cameco during the fourth quarter valued at $39,000. Ameriflex Group Inc. acquired a new stake in Cameco during the fourth quarter valued at $40,000. CoreCap Advisors LLC grew its position in Cameco by 8,363.6% during the fourth quarter. CoreCap Advisors LLC now owns 931 shares of the basic materials company's stock valued at $48,000 after buying an additional 920 shares during the period. Finally, Private Trust Co. NA grew its position in Cameco by 315.2% during the first quarter. Private Trust Co. NA now owns 1,229 shares of the basic materials company's stock valued at $51,000 after buying an additional 933 shares during the period. Institutional investors and hedge funds own 70.21% of the company's stock.

Cameco Price Performance

CCJ traded up $1.85 on Thursday, reaching $78.04. 5,378,380 shares of the company's stock were exchanged, compared to its average volume of 4,599,400. The stock has a market cap of $33.97 billion, a PE ratio of 195.11 and a beta of 1.03. Cameco Corporation has a twelve month low of $35.00 and a twelve month high of $78.49. The stock's fifty day moving average price is $64.24 and its 200-day moving average price is $52.15. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.70 and a quick ratio of 1.26.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last posted its quarterly earnings results on Thursday, May 1st. The basic materials company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by ($0.07). The business had revenue of $549.58 million for the quarter, compared to analyst estimates of $890.07 million. Cameco had a return on equity of 4.47% and a net margin of 7.50%. The business's revenue was up 24.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.13 earnings per share. Sell-side analysts expect that Cameco Corporation will post 1.27 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Scotiabank restated an "outperform" rating on shares of Cameco in a research report on Tuesday, July 8th. Raymond James Financial reiterated an "outperform" rating on shares of Cameco in a research report on Wednesday, June 18th. Royal Bank Of Canada lifted their target price on shares of Cameco from $90.00 to $100.00 and gave the company an "outperform" rating in a research report on Friday, June 20th. Desjardins initiated coverage on shares of Cameco in a research report on Friday, April 4th. They issued a "buy" rating on the stock. Finally, UBS Group reiterated a "buy" rating on shares of Cameco in a research report on Tuesday, June 10th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $80.65.

Cameco Company Profile

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.